Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Oxaliplatin 81 S 1 (combination) 55 Capecitabine 44 apatinib 32 Paclitaxel 32 Docetaxel 32 Irinotecan 27 Fluorouracil 22 Drug Therapy 21 sintilimab 20 Cisplatin 20 Leucovorin 16 Hyperthermic Intraperitoneal Chemotherapy 13 XELOX 12 Surgical Procedures, Operative 12 camrelizumab 10 Trastuzumab 10 titanium silicide 9 Tegafur 9 Nivolumab 9 Neoadjuvant Therapy 9 pembrolizumab 8 Laparoscopy 8 Gastrectomy 8 Folfox protocol 7 Chemotherapy, Adjuvant 7 toripalimab 6 tislelizumab 6 Ramucirumab 6 Gastroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Stomach Neoplasms × ipatasertib × Clear all

NCT04739202 2021-03-29

IMMUNOGAST

Hospices Civils de Lyon

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡